AEON Biopharma, Inc.
AEONHealthcare|Biotechnology|US
$0.18
+0.02 (+11.26%)
Cash / Share
$0.07
Clinical Trials (4)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT04849988 A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia | Cervical Dystonia | P2 | Completed | 61 | RCT, Double-blind | ABP-450, Placebo |
| NCT04871451 Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia | Cervical Dystonia | P2 | Completed | 51 | Open-label | ABP-450 |
| NCT04845178 Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults | Migraine | P2 | Completed | 797 | RCT, Double-blind | ABP-450, Placebo |
| NCT05016661 Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention | Migraine | P2 | Terminated | 466 | RCT, Double-blind | ABP-450 |